NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach.
- DOI
- 10.1016/j.omton.2026.201205
- Published
- 2026 Jun 18
- Container
- Molecular therapy. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omton.2026.201205,
title = {NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach.},
author = {Chen Y and Jiang Z and Jin S and Liu M and Chen M and Kuo TC and Zhou K and Pu L and Chen M and Chen S and Li X and Chen AS and Xie J and Zhang H and Wang Q and Xu J and Sheng J and Huang Y and Chen G},
year = {2026},
journal = {Molecular therapy. Oncology},
doi = {10.1016/j.omton.2026.201205},
url = {https://doi.org/10.1016/j.omton.2026.201205}
}RIS
TY - JOUR TI - NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach. AU - Chen Y AU - Jiang Z AU - Jin S AU - Liu M AU - Chen M AU - Kuo TC AU - Zhou K AU - Pu L AU - Chen M AU - Chen S AU - Li X AU - Chen AS AU - Xie J AU - Zhang H AU - Wang Q AU - Xu J AU - Sheng J AU - Huang Y AU - Chen G PY - 2026 JO - Molecular therapy. Oncology DO - 10.1016/j.omton.2026.201205 UR - https://doi.org/10.1016/j.omton.2026.201205 ER -
APA
Y, C., Z, J., S, J., M, L., M, C., TC, K., K, Z., L, P., M, C., S, C., X, L., AS, C., J, X., H, Z., Q, W., J, X., J, S., Y, H., & G, C. (2026). NeuroD1 gene therapy inhibits glioma growth and extends life span through in vivo reprogramming approach.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2026.201205
Source records
- pubmed · retrieved 2026-09-25T22:43:34.314Z